Amgen Inc (AMGN) Receives a Buy from Goldman Sachs


In a report issued on December 7, Terence Flynn from Goldman Sachs maintained a Buy rating on Amgen Inc (AMGN), with a price target of $232. The company’s shares closed on Friday at $191.44.

Flynn has an average return of 18.1% when recommending Amgen Inc.

According to TipRanks.com, Flynn is ranked #531 out of 5106 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Amgen Inc with a $207.23 average price target, which is an 8.2% upside from current levels. In a report issued on December 4, Oppenheimer also assigned a Buy rating to the stock with a $224 price target.

.

See today’s analyst top recommended stocks >>

Amgen Inc’s market cap is currently $124.2B and has a P/E ratio of 51.68. The company has a Price to Book ratio of 8.66.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts